Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 12, 2024 08:30 ET | Source: SeaStar Medical Holding Corporation

SeaStar Medical Provides Updates on Enrollment of Adult Pivotal Clinical Study and Commercial Launch of Quelimmune, FDA-Approved in Pediatric Patients

Company plans to hold a business update conference call in April DENVER, March 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial stage medical device...
December 29, 2023 12:00 ET | Source: Thumzup Media Corporation

Thumzup Reg A+ Offering Minimum Investment has been Reduced to $450

Advertiser Growth Up 2,950% Since Commercial Launch in Late 2022 Reg A+ Offering Ends on January 10, 2024 Earn Up to 30% Bonus Shares for Larger Investment Amounts More Than $1.6...
January 07, 2019 08:00 ET | Source: Tauriga Sciences

Tauriga Sciences, Inc. to Launch an E-Commerce Site to Coincide with the Commercial Launch of its Cannabis/CBD Infused Chewing Gum Product Line

NEW YORK, NY, Jan. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (TAUG) (“Tauriga” or the “Company”), engaged in building its business through the development,...
January 08, 2018 16:41 ET | Source: Adamas Pharmaceuticals, Inc.

Adamas Announces U.S. Commercial Launch of GOCOVRI™ the First and Only FDA-approved Medication for the Treatment of Dyskinesia in Parkinson’s Disease Patients

EMERYVILLE, Calif., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced the full commercial launch of its flagship product, GOCOVRI™ (amantadine) extended...
May 16, 2017 07:00 ET | Source: Great Basin Scientific, Inc.

Great Basin Scientific Announces Commercial Launch of Bordetella Direct Test

SALT LAKE CITY, May 16, 2017 (GLOBE NEWSWIRE) -- Great Basin Scientific, Inc. (OTCQB:GBSN), a molecular diagnostics company, today announced the U.S. commercial launch of its Bordetella Direct Test...